R&D

Our Teams

R&D Teams

Qingmu has established a professional, diversified and international R&D team. 40% of the Scientists are educated with Master or Ph.D degree. The key personnel are experts with Ph.D. degree and experienced in R&D and management of pharmaceutical industry.

Dr. Zhang Tangzhi

Head of CDMO Center

Ph.D. in Organic Chemistry at Shanghai institute of Organic Chemistry
post doctorial at Harvard Medical School
Worked as Scientist at Medichem, Hengrui pharma, VP of Acmebiopharma and General Manager of LinkChem.

Dr. Hua Zhu

Chief Technical Officer

Ph.D. in Chemistry at Tohoku University,
10 years experience in chemical synthesis,
Dr. Zhu worked for Hamari Chemicals, Ltd.，Bright Future Pharmaceutical Laboratories Ltd. and Hainan Bikai Medical Institute Ltd.

Technical Platform

Based on R&D concept “Green Chemistry “, Qingmu has gradually established key technical platforms such as asymmetric synthesis, transition metal catalysis (Cu, Fe, etc.), microchannel production, enzyme catalysis and drug crystallization process.

Till April 2022, Qingmu has applied 53 invention patents and successfully used in more than 20 commercial projects.

8 Hit API products including Ticagrelor, Dabigatran etexilate mesylate and Bisoprolol fumarate, have commercial supplying in main regulatated markets such as Europe, USA and Japan. More than 10 projects are under development or regulatory stage.

R&D Lab

Qingmu established a R&D laboratory with about 2000m², which can realize sample preparation from mg level to kgs level. The laboratory is equipped with membrane concentration, microchannel continuous flow reaction device, DAC50 and other devices to meet the needs of different processes.

The laboratory is equipped with more than 40 sets of HPLC and GC, covering various types of apparatus such as UV, DAD, CDA, RID, FLD, MS, MS-MS, ICP-MS, TGA, DSC, Malvern Particle sizer, etc., which can meet the analysis requirements of different compounds in R&D process.